Header Logo

Connection

SUSAN BLANEY to Matrix Metalloproteinase 9

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Matrix Metalloproteinase 9.
SUSAN BLANEY
Connection Strength
0.017
Matrix Metalloproteinase 9
  1. Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors. Pediatr Blood Cancer. 2007 Sep; 49(3):352-7.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.